| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |